msg placeholder Retry Now
msg placeholder
Publishing Comment () Sec
Edit Blog?
If you edit your live blog it will reset all the matrices.
Delete Blog?
This actions cannot be undone.
Edit Blog?
If you edit your live blog it will reset all the matrices.
Delete Blog?
This actions cannot be undone.
Lung Surfactants Market Size, Growth Drivers, and Trends 2030
saurabh maral
2 min read

Lung Surfactants Market Overview:

The Lung Surfactants Market is a critical component of the healthcare industry, playing a vital role in neonatal care and respiratory medicine. Lung surfactants are natural or synthetic substances that reduce surface tension in the lungs, facilitating the exchange of oxygen and carbon dioxide.

This market has experienced significant growth due to the rising incidence of respiratory distress syndrome (RDS) in premature infants and the prevalence of respiratory conditions in adults. As medical science advances and the need for advanced respiratory care intensifies, the Lung Surfactants market continues to evolve and expand, making it a crucial contributor to improved patient outcomes.

Key Players in the Lung Surfactants Market:

• CHIESI Farmaceutici S.p.A.

• ONY Biotech Inc

• Lyomark Pharma GmbH

• Windtree Therapeutics, Inc

• Aviva Systems Biology Corporation

• Boehringer Ingelheim International GmbH.

• Nanjing Norris Pharm Technology

• AbbVie Inc.

Lung Surfactants Market was USD 180.44 Million in 2022. It is projected to reach USD 245.53 Million by 2030, indicating a CAGR of 4.0% during the forecast period.

Market Segmentation:

By Drug Type

• Lucinactant

• Colfosceril Palmitate

• Beractant

• Calefacient

• Protectant Alfa

By Indication

• Respiratory Distress Syndrome (RDS)

• Respiratory Infections

• Others

By Distribution Channel

• Hospital Pharmacy

• Retail Pharmacy

• Online Pharmacy

• Others

By End User

• Hospitals

• Specialty Clinics

• Others

Click Here To Get: Lung Surfactants Market Trends

Regional Analysis:

North America is a prominent market for Lung Surfactants, driven by advanced healthcare infrastructure and a significant emphasis on neonatal and adult respiratory care. Europe follows closely, with countries like Germany and the United Kingdom leading in medical research and technology adoption. In Asia-Pacific, a rising awareness of respiratory conditions and improving healthcare systems contribute to market growth, with countries such as China and India showing promise. Latin America and the Middle East & Africa regions are also experiencing increasing demand for lung surfactants as healthcare access expands and the prevalence of respiratory disorders rises.

saurabh maral
More From saurabh maral
Comments ()
Most Liked
  • Most Liked
  • Most Recent
Delete This Reply?
This actions cannot be undone.
Delete This Comment?
This actions cannot be undone.
msg placeholder
msg placeholder